Lesional skin in atopic dogs shows a mixed Type-1 and Type-2 immune responsiveness

Veterinary Immunology and Immunopathology

Volumn 143, Issue 1-2, 2011, Pages 20-26

  Schlotter, Yvette M ^a   Rutten, Victor P M G ^b,c   Riemers, Frank M ^a   Knol, Edward F ^d   Willemse, Ton ^a,b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF PRETORIA   (South Africa)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Atopic dermatitis; Cytokines; Dogs; T cells; Transcription factors

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR BETA1; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; MESSENGER RNA; STAT4 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; SUPPRESSOR OF CYTOKINE SIGNALING 5; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATOPIC DERMATITIS; ATOPY; CELLULAR IMMUNITY; CONTROLLED STUDY; DOG; FEMALE; GENE EXPRESSION; IMMUNE RESPONSE; MALE; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; SKIN DEFECT; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL;

ANIMALS; BASE SEQUENCE; CASE-CONTROL STUDIES; CYTOKINES; DERMATITIS, ATOPIC; DNA PRIMERS; DOG DISEASES; DOGS; FEMALE; HUMANS; MALE; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH2 CELLS; TRANSCRIPTION FACTORS;

CANIS FAMILIARIS;

EID: 79961025726     PISSN: 01652427     EISSN: 18732534     Source Type: Journal    
DOI: 10.1016/j.vetimm.2011.05.025     Document Type: Article

References (53)

1. Akdis M. The cellular orchestra in skin allergy; are differences to lung and nose relevant?. Curr. Opin. Allergy Clin. Immunol. 2011, 10:443-451.
2. Arakawa S., Hatano Y., Katagiri K. Differential expression of mRNA for Th1 and Th2 cytokine-associated transcription factors and suppressors of cytokine signalling in peripheral blood mononuclear cells of patients with atopic dermatitis. Clin. Exp. Immunol. 2004, 135:505-510.
3. Biller B.J., Elmslie R.E., Burnett R.C., Avery A.C., Dow S.W. Use of FoxP3 expression to identify regulatory T cells in healthy dogs and dogs with cancer. Vet. Immunol. Immunopathol. 2007, 116:69-78.
4. Brinkhof B., Spee B., Rothuizen J., Penning L.C. Development and evaluation of canine reference genes for accurate quantification of gene expression. Anal. Biochem. 2006, 356:36-43.
5. Chen W., Khurana Hershey G.K. Signal transducer and activator of transcription signals in allergic disease. J. Allergy Clin. Immunol. 2007, 119:529-541. (quiz 542-543).
6. Couper K.N., Blount D.G., Riley E.M. IL-10: the master regulator of immunity to infection. J. Immunol. 2008, 180:5771-5777.
7. Elliott J., Johnston J.A. SOCS: role in inflammation, allergy and homeostasis. Trends Immunol. 2004, 25:434-440.
8. Favrot C., Steffan J., Seewald W., Picco F. A prospective study on the clinical features of chronic canine atopic dermatitis and its diagnosis. Vet. Dermatol. 2010, 21:23-31.
9. Fujiwara S., Yasunaga S., Iwabuchi S., Masuda K., Ohno K., Tsujimoto H. Cytokine profiles of peripheral blood mononuclear cells from dogs experimentally sensitized to Japanese cedar pollen. Vet. Immunol. Immunopathol. 2003, 93:9-20.
10. Gessner A., Mohrs K., Mohrs M. Mast cells, basophils, and eosinophils acquire constitutive IL-4 and IL-13 transcripts during lineage differentiation that are sufficient for rapid cytokine production. J. Immunol. 2005, 174:1063-1072.
11. Grewe M., Walther S., Gyufko K., Czech W., Schopf E., Krutmann J. Analysis of the cytokine pattern expressed in situ in inhalant allergen patch test reactions of atopic dermatitis patients. J. Invest. Dermatol. 1995, 105:407-410.
12. Griffin C.E., DeBoer D.J. The ACVD task force on canine atopic dermatitis (XIV): clinical manifestations of canine atopic dermatitis. Vet. Immunol. Immunopathol. 2001, 81:255-269.
13. Guttman-Yassky E., Nograles K.E., Krueger J.G. Contrasting pathogenesis of atopic dermatitis and psoriasis. Part II. Immune cell subsets and therapeutic concepts. J. Allergy Clin. Immunol. 2011.
14. Herrick C.A., Bottomly K. To respond or not to respond: T cells in allergic asthma. Nat. Rev. Immunol. 2003, 3:405-412.
15. Ho I.C., Tai T.S., Pai S.Y. GATA3 and the T-cell lineage: essential functions before and after T-helper-2-cell differentiation. Nat. Rev. Immunol. 2009, 9:125-135.
16. Huehn J., Polansky J.K., Hamann A. Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage?. Nat. Rev. Immunol. 2009, 9:83-89.
17. Jutel M., Akdis M., Budak F., Aebischer-Casaulta C., Wrzyszcz M., Blaser K., Akdis C.A. IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur. J. Immunol. 2003, 33:1205-1214.
18. Keppel K.E., Campbell K.L., Zuckermann F.A., Greeley E.A., Schaeffer D.J., Husmann R.J. Quantitation of canine regulatory T cell populations, serum interleukin-10 and allergen-specific IgE concentrations in healthy control dogs and canine atopic dermatitis patients receiving allergen-specific immunotherapy. Vet. Immunol. Immunopathol. 2008, 123:337-344.
19. Knisz J., Rothman P.B. Suppressor of cytokine signaling in allergic inflammation. J. Allergy Clin. Immunol. 2007, 119:739-745.
20. Langeveld-Wildschut E.G., Thepen T., Bihari I.C., ven Reijsen F.C., de Vries I.J., Bruijnzeel P.L., Bruijnzeel-Koomen C.A. Evaluation of the atopy patch test and the cutaneous late-phase reaction as relevant models for the study of allergic inflammation in patients with atopic eczema. J. Allergy Clin. Immunol. 1996, 98:1019-1027.
21. Larche M. Regulatory T cells in allergy and asthma. Chest 2007, 132:1007-1014.
22. Leung D.Y., Boguniewicz M., Howell M.D., Nomura I., Hamid Q.A. New insights into atopic dermatitis. J. Clin. Invest. 2004, 113:651-657.
23. Maeda S., Tsuchida H., Marsella R. Allergen challenge decreases mRNA expression of regulatory cytokines in whole blood of high-IgE beagles. Vet. Dermatol. 2007, 18:422-426.
24. Marsella R., Olivry T., Maeda S. Cellular and cytokine kinetics after epicutaneous allergen challenge (atopy patch testing) with house dust mites in high-IgE beagles. Vet. Dermatol. 2006, 17:111-120.
25. Mizuno T., Suzuki R., Umeki S., Okuda M. Crossreactivity of antibodies to canine CD25 and Foxp3 and identification of canine CD4+CD25+Foxp3+ cells in canine peripheral blood. J. Vet. Med. Sci. 2009, 71:1561-1568.
26. Mowen K.A., Glimcher L.H. Signaling pathways in Th2 development. Immunol. Rev. 2004, 202:203-222.
27. Nuttall T.J., Knight P.A., McAleese S.M., Lamb J.R., Hill P.B. Expression of Th1, Th2 and immunosuppressive cytokine gene transcripts in canine atopic dermatitis. Clin. Exp. Allergy 2002, 32:789-795.
28. Nuttall T.J., Knight P.A., McAleese S.M., Lamb J.R., Hill P.B. T-helper 1, T-helper 2 and immunosuppressive cytokines in canine atopic dermatitis. Vet. Immunol. Immunopathol. 2002, 87:379-384.
29. O'Garra A., Vieira P. Twenty-first century Foxp3. Nat. Immunol. 2003, 4:304-306.
30. Olivry T., Dean G.A., Tompkins M.B., Dow J.L., Moore P.F. Toward a canine model of atopic dermatitis: amplification of cytokine-gene transcripts in the skin of atopic dogs. Exp. Dermatol. 1999, 8:204-211.
31. Olivry T., Hill P.B. The ACVD task force on canine atopic dermatitis (XVIII): histopathology of skin lesions. Vet. Immunol. Immunopathol. 2001, 81:305-309.
32. Olivry T., Naydan D.K., Moore P.F. Characterization of the cutaneous inflammatory infiltrate in canine atopic dermatitis. Am. J. Dermatopathol. 1997, 19:477-486.
33. Ou L.S., Goleva E., Hall C., Leung D.Y. T regulatory cells in atopic dermatitis and subversion of their activity by superantigens. J. Allergy Clin. Immunol. 2004, 113:756-763.
34. Prefontaine D., Fiset P.O., Hamid Q. Transcription factors in allergic diseases. J. Allergy Clin. Immunol. 2007, 119:761-764.
35. Purwar R., Kraus M., Werfel T., Wittmann M. Modulation of keratinocyte-derived MMP-9 by IL-13: a possible role for the pathogenesis of epidermal inflammation. J. Invest. Dermatol. 2008, 128:59-66.
36. Purwar R., Werfel T., Wittmann M. IL-13-stimulated human keratinocytes preferentially attract CD4+CCR4+ T cells: possible role in atopic dermatitis. J. Invest. Dermatol. 2006, 126:1043-1051.
37. Robinson D.S., Lloyd C.M. Asthma: T-bet - a master controller?. Curr. Biol. 2002, 12:R322-R324.
38. Schlotter Y.M., Veenhof E.Z., Brinkhof B., Rutten V.P., Spee B., Willemse T., Penning L.C. A GeNorm algorithm-based selection of reference genes for quantitative real-time PCR in skin biopsies of healthy dogs and dogs with atopic dermatitis. Vet. Immunol. Immunopathol. 2009, 129:115-118.
39. Seki Y., Hayashi K., Matsumoto A., Seki N., Tsukada J., Ransom J., Naka T., Kishimoto T., Yoshimura A., Kubo M. Expression of the suppressor of cytokine signaling-5 (SOCS5) negatively regulates IL-4-dependent STAT6 activation and Th2 differentiation. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:13003-13008.
40. Seki Y., Inoue H., Nagata N., Hayashi K., Fukuyama S., Matsumoto K., Komine O., Hamano S., Himeno K., Inagaki-Ohara K., Cacalano N., O'Garra A., Oshida T., Saito H., Johnston J.A., Yoshimura A., Kubo M. SOCS-3 regulates onset and maintenance of T(H)2-mediated allergic responses. Nat. Med. 2003, 9:1047-1054.
41. Sinke J.D., Rutten V.P., Willemse T. Immune dysregulation in atopic dermatitis. Vet. Immunol. Immunopathol. 2002, 87:351-356.
42. Sinke J.D., Thepen T., Bihari I.C., Rutten V.P., Willemse T. Immunophenotyping of skin-infiltrating T-cell subsets in dogs with atopic dermatitis. Vet. Immunol. Immunopathol. 1997, 57:13-23.
43. Spee B., Penning L.C., van den Ingh T.S., Arends B., Ijzer J., van Sluijs F.J., Rothuizen J. Regenerative and fibrotic pathways in canine hepatic portosystemic shunt and portal vein hypoplasia, new models for clinical hepatocyte growth factor treatment. Comp. Hepatol. 2005, 4:7.
44. Thepen T., Langeveld-Wildschut E.G., Bihari I.C., van Wichen D.F., van Reijsen F.C., Mudde G.C., Bruijnzeel-Koomen C.A. Biphasic response against aeroallergen in atopic dermatitis showing a switch from an initial TH2 response to a TH1 response in situ: an immunocytochemical study. J. Allergy Clin. Immunol. 1996, 97:828-837.
45. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 2003, 3:133-146.
46. Veenhof E.Z., Rutten V.P., van Noort R., Knol E.F., Willemse T. Evaluation of T-cell activation in the duodenum of dogs with cutaneous food hypersensitivity. Am. J. Vet. Res. 2010, 71:441-446.
47. Verhagen J., Akdis M., Traidl-Hoffmann C., Schmid-Grendelmeier P., Hijnen D., Knol E.F., Behrendt H., Blaser K., Akdis C.A. Absence of T-regulatory cell expression and function in atopic dermatitis skin. J. Allergy Clin. Immunol. 2006, 117:176-183.
48. Watford W.T., Hissong B.D., Bream J.H., Kanno Y., Muul L., O'Shea J.J. Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4. Immunol. Rev. 2004, 202:139-156.
49. Willemse A. Atopic skin disease: a review and a reconsideration of diagnostic criteria. J. Small Anim. Pract. 1986, 771-778.
50. Wills-Karp M., Finkelman F.D. Untangling the complex web of IL-4- and IL-13-mediated signaling pathways. Sci. Signal. 2008, 1:pe55.
51. Wu K., Bi Y., Sun K., Wang C. IL-10-producing type 1 regulatory T cells and allergy. Cell Mol. Immunol. 2007, 4:269-275.
52. Yoshimura A., Naka T., Kubo M. SOCS proteins, cytokine signalling and immune regulation. Nat. Rev. Immunol. 2007, 7:454-465.
53. Zheng T., Oh M.H., Oh S.Y., Schroeder J.T., Glick A.B., Zhu Z. Transgenic expression of interleukin-13 in the skin induces a pruritic dermatitis and skin remodeling. J. Invest. Dermatol. 2009, 129:742-751.